Potential effects of genetic variations in fusion protein on the virulence of human respiratory syncytial virus
-
By
-
Jingjing Song
-
Na Wang
-
Zhen Zhu
-
Naiying Mao
-
Hai Li
-
Jinhua Song
-
Lei Cao
-
Baicheng Xia
-
Min Liao
-
Wuyang Zhu
-
Yan Zhang
-
July 3, 2026
-
Clinical Scorecard: Impact of Genetic Variants in Fusion Protein on the Pathogenicity of Human Respiratory Syncytial Virus
At a Glance
| Category | Detail |
|---|
| Condition | Human Respiratory Syncytial Virus (HRSV) |
| Key Mechanisms | F protein genetic variations influence viral replication dynamics and pathogenicity. |
| Target Population | Infants at risk for acute lower respiratory infections (ALRIs). |
| Care Setting | Laboratory and animal models for viral research. |
Key Highlights
- Recombinant HRSV strains showed attenuated replication kinetics compared to the parental strain.
- rLong-SY2103-BF exhibited greater pathogenicity than rLong-BJ1903-AF.
- Both recombinant viruses caused less severe disease than the Long-BAC strain.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Infants with HRSV-associated ALRIs.
Focus on antiviral and immunological strategies targeting HRSV.
Clinical Best Practices
- Utilize reverse genetics for studying viral pathogenicity.
- Monitor genetic variations in HRSV for potential impacts on immune response.
Related Resources & Content
